AIDS TREATMENT ACTIVISTS COALITION (ATAC)
GLAXOSMITHKLINE
ATAC DDC Liaisons: Ken Fornataro, Tom Gegeny
COMPANY INFORMATION
CONTACT INFORMATION
Michael N. Joyner
Manager, HIV Patient Advocacy Relations
GlaxoSmithKline
P. O. Box 13398
Research Triangle Park, NC 27709
E-mail: [email protected]
Telephone: (919) 483-2987
Fax: (919) 483-0571
PRODUCT INFORMATION
1. FDA-Approved Products:
- Nucleoside analogue reverse transcriptase inhibitors:
- abacavir (Ziagen®)
- lamivudine (Epivir® 3TC)
- zidovudine (Retrovir&areg; AZT, ZDV)
- zidovudine/lamivudine (Combivir®)
- zidovudine/lamivudine/abacavir (Trizivir®)
- Protease inhibitor: amprenavir (Agenerase®)
2. Products in Clinical Trials:
Protease inhibitor GW433908 (pro-drug of Amprenavir)
Fusion inhibitor
Integrase inhibitor
Web pages:
Go to Main Page
E-mail
the Coalition
ATAC is a national coalition of people living
with HIV/AIDS and advocates working together to end the AIDS epidemic
by improving HIV research and treatment access.